Skip to content

A Real-World Study of Individualized Treatment with Antipsychotic Medications in the Chinese Han Population

A Real-World Study of Individualized Treatment with Antipsychotic Medications in the Chinese Han Population

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076114
Enrollment
Unknown
Registered
2023-09-25
Start date
2023-09-30
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Inpatient with schizophrenia:NA

Sponsors

Peking University Sixth Hospital, Peking University Institute of Mental Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Ages 18 to 60, male or female, Han ethnicity; 2) Inpatients; 3) Meet the diagnostic criteria for schizophrenia according to ICD-10; 4) Baseline Positive and Negative Syndrome Scale (PANSS) score = 60; 5) Completed at least middle school education, with no language barriers, capable of participating in assessments and treatment; 6) Patients have voluntarily purchased and undergone the Zhen Hui Xuan® testing, and have signed the informed consent for testing. 7) Written informed consent obtained from patients; if the patient lacks capacity to provide consent during the onset period, written informed consent from their legal guardian is required.

Exclusion criteria

Exclusion criteria: 1) Patients with severe physical illnesses (such as metabolic diseases, kidney diseases, liver diseases, thyroid diseases, etc.) or organic brain diseases; 2) A history of consciousness loss lasting over 5 minutes in the past; 3) History of alcohol or substance abuse/dependence within the past year prior to enrollment; 4) Regular use of addictive drugs within the last month prior to enrollment; 5) Received Modified Electroconvulsive Therapy (MECT) treatment within the last month prior to enrollment; 6) Individuals with severe suicidal tendencies or risk of harming others; 7) Presence of other significant psychiatric disorders (such as personality disorders and intellectual disabilities) significantly affecting the patient's current mental state; 8) Pregnant or breastfeeding women, or those planning pregnancy; 9) Conditions deemed by the investigator as not meeting the criteria for this clinical study.

Design outcomes

Primary

MeasureTime frame
Positive and Negative Syndrome Scale;

Secondary

MeasureTime frame
Clinical Global Impression-Severity (CGI-S) Scale;

Countries

China

Contacts

Public ContactWeihua Yue

The Sixth Hospital / Institute of Mental Health, Peking University

dryue@bjmu.edu.cn+86 10 8280 5307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026